Supplemental Figure 1
1
0 5 10 15 20 25 0 0.25 0.5 0.75 1 f(x) = − 0.182970663220846 ln(x) + 0.977925085752234 R² = 0.901256419179842 AsPC-1 Exponen tial (AsPC- 1) uM ICG-001 Relative Proliferation Cell Line IC50 (μM) AsPC-1 5.48 L3.6pl 14.07 PANC-1 3.43 MiaPaCa- 2 3.31 Supplemental Figure 1 A B Supplemental Figure 1. (A) Dose response curves from MTT assays at 6 days of treatment with indicated concentrations of ICG-001. (B) IC50 values for PDAC cell lines after treatment with ICG-001.
description
Supplemental Figure 1. A. B. Supplemental Figure 1. (A) Dose response curves from MTT assays at 6 days of treatment with indicated concentrations of ICG-001. (B) IC50 values for PDAC cell lines after treatment with ICG-001. - PowerPoint PPT Presentation
Transcript of Supplemental Figure 1
![Page 1: Supplemental Figure 1](https://reader038.fdocument.org/reader038/viewer/2022110211/568132d5550346895d999896/html5/thumbnails/1.jpg)
0 5 10 15 20 250
0.25
0.5
0.75
1
f(x) = − 0.182970663220846 ln(x) + 0.977925085752234R² = 0.901256419179842
AsPC-1
Exponen-tial (AsPC-1)
L3.6pl
uM ICG-001
Rela
tive
Prol
ifera
tion
Cell Line IC50 (μM)AsPC-1 5.48L3.6pl 14.07
PANC-1 3.43MiaPaCa-2 3.31
Supplemental Figure 1
A
B
Supplemental Figure 1. (A) Dose response curves from MTT assays at 6 days of treatment with indicated concentrations of ICG-001. (B) IC50 values for PDAC cell lines after treatment with ICG-001.